69% Being on an effective treatment, independent of the stage of disease How involved are patients in the treatment decision-making process? What is the most important aspect of living with IPF? 64% of patients said they were involved 30% of patients said they were not involved 6% do not know INSIGHTS INTO IPF PATIENT AND PHYSICIAN TREATMENT DISCUSSIONS AND PRIORITIES What are the top 3 treatment priorities? Knowing what treatment options are available A top priority for 74% of patients* Believed by 77% of physicians** to be a top patient priority For more information on IPF and the survey results please visit www.lifewithipf.com *Data on file. Boehringer Ingelheim. Think of Everything Global Patient Survey. 2016. Global survey of 152 patients from 9 countries to gain their insights on idiopathic pulmonary fibrosis (IPF) **Data on file. Boehringer Ingelheim. Think of Everything Global Pulmonologist Survey. 2015. Results from this patient survey have been compared with results from a 2015 global survey of over 400 pulmonologists; Responses from pulmonologists when asked what they believed their patients’ priorities were Of the 64% of patients who said they were involved when agreeing on an appropriate treatment… 58% Maintaining lung function for as long as possible 14% Reducing the risk of sudden worsening of my condition 12% Being on a medication with manageable side-effects P A T I E N T V I E W S * 29% only had a brief discussion with their doctor P H Y S I C I A N V I E W S O N P A T I E N T P R I O R I T I E S * * 83% Being on a treatment that allows me to continue my day-to-day activities 67% Maintaining lung function for as long as possible said further discussion was not needed and they preferred to strictly follow their doctor's recommendation 30% 40% were actively involved in open discussions with their doctor